The two slopes of the BCRABL mRNA decline curves (3-4 log reduction) could be consistent with the eradication of differentiated mature CML cells (fast slope) and leukemic progenitors (slow slope). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.